Moderna 2026 Covid and RSV growth not enough to boost stock, Jefferies saysProactive Investors • 12/12/25
Moderna (MRNA) Recently Broke Out Above the 50-Day Moving AverageZacks Investment Research • 12/08/25
Moderna (MRNA) Recently Broke Out Above the 20-Day Moving AverageZacks Investment Research • 12/04/25
Moderna, Inc. (MRNA) Presents at Piper Sandler 37th Annual Healthcare Conference TranscriptSeeking Alpha • 12/02/25
Vaccine Stocks Fall After FDA Plans to Impose Stricter Vaccine RulesZacks Investment Research • 12/02/25
S&P 500 Gains and Losses Today: Moderna Falls; Synopsys Stock Climbs on Nvidia PartnershipInvestopedia • 12/01/25
Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young menMarket Watch • 12/01/25
Moderna, BioNTech Slammed After FDA Links Covid Shots To 10 DeathsInvestors Business Daily • 12/01/25
Moderna to Present at Upcoming Piper Sandler's 37th Annual Healthcare Conference on December 2, 2025Accesswire • 11/18/25